TipRanks
Advertisement
Advertisement

IVVD Stock Latest News

Invivyd Phase 3 data supports VYD2311 tolerability, says H.C. Wainwright
The FlyInvivyd Phase 3 data supports VYD2311 tolerability, says H.C. Wainwright
13d ago
IVVD
Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety
PremiumCompany Announcements
Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety
13d ago
8K
IVVD
Invivyd announces results from LIBERTY Phase 3 study of VYD2311
PremiumThe Fly
Invivyd announces results from LIBERTY Phase 3 study of VYD2311
13d ago
IVVD
Invivyd management to meet virtually with BTIG
PremiumThe Fly
Invivyd management to meet virtually with BTIG
1M ago
IVVD
Cantor says Invivyd should be trading ‘meaningfully higher’ after update
PremiumThe Fly
Cantor says Invivyd should be trading ‘meaningfully higher’ after update
1M ago
IVVD
Invivyd appoints Marc Elia CEO amid board reshuffle
PremiumCompany AnnouncementsInvivyd appoints Marc Elia CEO amid board reshuffle
1M ago
8K
IVVD
Invivyd appoints Marc Elia as CEO
Premium
The Fly
Invivyd appoints Marc Elia as CEO
1M ago
IVVD
Invivyd provides update on VYD2311 program, DECLARATION study
Premium
The Fly
Invivyd provides update on VYD2311 program, DECLARATION study
1M ago
IVVD
Invivyd’s Nasdaq Listing at Risk: Potential Delisting Threatens Financing Access and Market Value
PremiumCompany Announcements
Invivyd’s Nasdaq Listing at Risk: Potential Delisting Threatens Financing Access and Market Value
2M ago
IVVD
Invivyd Receives Nasdaq Notice for Bid Price Deficiency
PremiumCompany Announcements
Invivyd Receives Nasdaq Notice for Bid Price Deficiency
3M ago
8K
IVVD
Invivyd: Buy Rating Reiterated as PEMGARDA EUA Transition Seen as Administrative; $10 Price Target Unchanged
PremiumRatings
Invivyd: Buy Rating Reiterated as PEMGARDA EUA Transition Seen as Administrative; $10 Price Target Unchanged
3M ago
IVVD
Invivyd Plans Post-EUA Pathway for PEMGARDA Antibody
PremiumCompany Announcements
Invivyd Plans Post-EUA Pathway for PEMGARDA Antibody
3M ago
8K
IVVD
Invivyd announces notice of termination for Pemgarda Emergency Use Authorization
PremiumThe FlyInvivyd announces notice of termination for Pemgarda Emergency Use Authorization
3M ago
IVVD
Invivyd completes enrollment of LIBERTY clinical trial
Premium
The Fly
Invivyd completes enrollment of LIBERTY clinical trial
4M ago
IVVD
Shrader Reiterates Buy on Invivyd, Maintains $10 Price Target on Strong VYD2311 Prospects and High-Risk Population Opportunity
Premium
Ratings
Shrader Reiterates Buy on Invivyd, Maintains $10 Price Target on Strong VYD2311 Prospects and High-Risk Population Opportunity
4M ago
IVVD
Invivyd completes enrollment in DECLARATION trial
PremiumThe Fly
Invivyd completes enrollment in DECLARATION trial
4M ago
IVVD
Invivyd: Buy Rating Reiterated as Clinical and Regulatory Progress Supports Unchanged $10 Price Target
PremiumRatings
Invivyd: Buy Rating Reiterated as Clinical and Regulatory Progress Supports Unchanged $10 Price Target
5M ago
IVVD
Invivyd Shareholders Reelect Board, Ratify PwC Auditor
PremiumCompany Announcements
Invivyd Shareholders Reelect Board, Ratify PwC Auditor
5M ago
8K
IVVD
Invivyd management to meet with BTIG
PremiumThe Fly
Invivyd management to meet with BTIG
5M ago
IVVD
Invivyd Earnings Call Highlights Trial Progress, Growth
PremiumCompany AnnouncementsInvivyd Earnings Call Highlights Trial Progress, Growth
5M ago
IVVD
Invivyd post earnings selloff overdone, says H.C. Wainwright
Premium
The Fly
Invivyd post earnings selloff overdone, says H.C. Wainwright
5M ago
IVVD
Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs
Premium
Company Announcements
Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs
5M ago
8K
IVVD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >